Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer.
Landi L, D'Incà F, Gelibter A, Chiari R, Grossi F, Delmonte A, Passaro A, Signorelli D, Gelsomino F, Galetta D, Giannarelli D, Soto Parra H, Minuti G, Tiseo M, Migliorino MR, Cognetti F, Toschi L, Bidoli P, Piantedosi F, Calabro' L, Cappuzzo F. Landi L, et al. Among authors: cappuzzo f. J Immunother Cancer. 2019 Nov 21;7(1):316. doi: 10.1186/s40425-019-0793-8. J Immunother Cancer. 2019. PMID: 31752994 Free PMC article.
Gemcitabine in non-small cell lung cancer.
Crinò L, Cappuzzo F. Crinò L, et al. Among authors: cappuzzo f. Expert Opin Pharmacother. 2002 Jun;3(6):745-53. doi: 10.1517/14656566.3.6.745. Expert Opin Pharmacother. 2002. PMID: 12036414 Review.
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
Cappuzzo F, Selvaggi G, Gregorc V, Mazzoni F, Betti M, Rita Migliorino M, Novello S, Maestri A, De Marinis F, Darwish S, De Angelis V, Nelli F, Bartolini S, Scagliotti GV, Tonato M, Crinò L. Cappuzzo F, et al. Cancer. 2003 Jul 1;98(1):128-34. doi: 10.1002/cncr.11460. Cancer. 2003. PMID: 12833465 Free article. Clinical Trial.
Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.
Cappuzzo F, Gregorc V, Rossi E, Cancellieri A, Magrini E, Paties CT, Ceresoli G, Lombardo L, Bartolini S, Calandri C, de Rosa M, Villa E, Crino L. Cappuzzo F, et al. J Clin Oncol. 2003 Jul 15;21(14):2658-63. doi: 10.1200/JCO.2003.01.039. J Clin Oncol. 2003. PMID: 12860941 Clinical Trial.
Emerging drugs for non-small cell lung cancer.
Cappuzzo F, Bartolini S, Crinò L. Cappuzzo F, et al. Expert Opin Emerg Drugs. 2003 May;8(1):179-92. doi: 10.1517/14728214.8.1.179. Expert Opin Emerg Drugs. 2003. PMID: 14610920 Review.
309 results